Newman Clinic Review

Our assessment

What Newman Clinic does that almost nobody else does is price a much cheaper non-GLP-1 option right beside the two GLP-1 lanes, so you can see the alternative instead of only being sold the expensive one. Each drug gets one figure, and each is an as-low-as floor, with the medication, the support and the shipping folded into a monthly membership. The clinic names its own professional entity. It also holds an FDA warning letter, over the same-ingredient framing it uses on that page.

Two floors and a third option

The weight-management page presents three choices side by side with a price under each, and every price is an as-low-as figure. No dose ladder appears, and no plan term sits beside any of them, so nothing tells you what pushes a bill above the floor.

The third choice isn't a GLP-1 at all. It is an older oral appetite suppressant at a fraction of the price. Putting it on the same page as the two GLP-1 lanes, priced, is unusual and useful: you see what the cheaper route costs before a consultation frames the expensive one as the only option.

What the membership covers

The individual drug pages describe a monthly membership that includes expert support, medication and free shipping. So the published figure is a membership charge rather than a drug price with fees still to come, which is the more useful of the two shapes.

It also means the floor is the floor of a bundle. Without a dose ladder, nothing on the page tells you how far above it a higher dose would land you.

The same-ingredient framing

Each GLP-1 option is labeled with the phrase that its compounded preparation shares an active ingredient with named brand-name products. That framing is the subject of the clinic's FDA warning letter, which concerns false and misleading claims about compounded medication.

A warning letter of this kind is about how a website describes a product, not about what is in the vial. It is worth knowing about, and worth reading in the agency's own words.